|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Besse B, Adjei A, Baas P, Meldgaard P,
Nicolson M, Paz-Ares L, Reck M, Smit EF, Syrigos K, Stahel R, et
al: 2nd ESMO consensus conference on lung cancer: Non-small-cell
lung cancer first-line/second and further lines of treatment in
advanced disease. Ann Oncol. 25:1475–1484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Burt M, Heelan RT, Coit D, McCormack PM,
Bains MS, Martini N, Rusch V and Ginsberg RJ: Prospective
evaluation of unilateral adrenal masses in patients with operable
non-small-cell lung cancer. Impact of magnetic resonance imaging. J
Thorac Cardiovasc Surg. 107:584–599. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawai N, Tozawa K, Yasui T, Moritoki Y,
Sasaki H, Yano M, Fujii Y and Kohri K: Laparoscopic adrenalectomy
for solitary adrenal metastasis from lung cancer. JSLS.
18:e2014.00062. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Porte HL, Roumilhac D, Graziana JP, Eraldi
L, Cordonier C, Puech P and Wurtz AJ: Adrenalectomy for a solitary
adrenal metastasis from lung cancer. Ann Thorac Surg. 65:331–335.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gao XL, Zhang KW, Tang MB, Zhang KJ, Fang
LN and Liu W: Pooled analysis for surgical treatment for isolated
adrenal metastasis and non-small cell lung cancer. Interact
Cardiovasc Thorac Surg. 24:1–7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Holy R, Piroth M, Pinkawa M and Eble MJ:
Stereotactic body radiation therapy (SBRT) for treatment of adrenal
gland metastases from non-small cell lung cancer. Strahlenther
Onkol. 187:245–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cao L, Yang H, Yao D, Cai H, Wu H, Yu Y,
Zhu L, Xu W, Liu Y and Li J: Clinical-imaging-radiomic nomogram
based on unenhanced CT effectively predicts adrenal metastases in
patients with lung cancer with small hyperattenuating adrenal
incidentalomas. Oncol Lett. 28:3402024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brady MJ, Thomas J, Wong TZ, Franklin KM,
Ho LM and Paulson EK: Adrenal nodules at FDG PET/CT in patients
known to have or suspected of having lung cancer: A proposal for an
efficient diagnostic algorithm. Radiology. 250:523–530. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeiger MA, Siegelman SS and Hamrahian AH:
Medical and surgical evaluation and treatment of adrenal
incidentalomas. J Clin Endocrinol Metab. 96:2004–2015. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cao L, Yang H, Wu H, Zhong H, Cai H, Yu Y,
Zhu L, Liu Y and Li J: Adrenal indeterminate nodules: CT-based
radiomics analysis of different machine learning models for
predicting adrenal metastases in lung cancer patients. Front Oncol.
14:14112142024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Caoili EM, Korobkin M, Francis IR, Cohan
RH, Platt JF, Dunnick NR and Raghupathi KI: Adrenal masses:
Characterization with combined unenhanced and delayed enhanced CT.
Radiology. 222:629–633. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fujiyoshi F, Nakajo M, Fukukura Y and
Tsuchimochi S: Characterization of adrenal tumors by chemical shift
fast low-angle shot MR imaging: Comparison of four methods of
quantitative evaluation. AJR Am J Roentgenol. 180:1649–1657. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mayo-Smith WW, Song JH, Boland GL, Francis
IR, Israel GM, Mazzaglia PJ, Berland LL and Pandharipande PV:
Management of incidental adrenal masses: A white paper of the ACR
incidental findings committee. J Am Coll Radiol. 14:1038–1044.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Haider MA, Ghai S, Jhaveri K and Lockwood
G: Chemical shift MR imaging of hyperattenuating (>10 HU)
adrenal masses: Does it still have a role? Radiology. 231:711–716.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Koo HJ, Choi HJ, Kim HJ, Kim SO and Cho
KS: The value of 15-minute delayed contrast-enhanced CT to
differentiate hyperattenuating adrenal masses compared with
chemical shift MR imaging. Eur Radiol. 24:1410–1420. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hsiao R, Chow A, Kluijfhout WP, Bongers
PJ, Verzijl R, Metser U, Veit-Haibach P and Pasternak JD: The
clinical consequences of functional adrenal uptake in the absence
of cross-sectional mass on FDG-PET/CT in oncology patients.
Langenbecks Arch Surg. 407:1677–1684. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Arikan AE, Makay O, Teksoz S, Vatansever
S, Alptekin H, Albeniz G, Demir A, Ozpek A and Tunca F: Efficacy of
PET-CT in the prediction of metastatic adrenal masses that are
detected on follow-up of the patients with prior nonadrenal
malignancy: A nationwide multicenter case-control study. Medicine
(Baltimore). 101:e302142022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lang BH, Cowling BJ, Li JY, Wong KP and
Wan KY: High false positivity in positron emission tomography is a
potential diagnostic pitfall in patients with suspected adrenal
metastasis. World J Surg. 39:1902–1908. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Detterbeck FC, Woodard GA, Bader AS, Dacic
S, Grant MJ, Park HS and Tanoue LT: The proposed ninth edition TNM
classification of lung cancer. Chest. 166:882–895. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Vos EL, Grewal RK, Russo AE, Reidy-Lagunes
D, Untch BR, Gavane SC, Boucai L, Geer E, Gopalan A, Chou JF, et
al: Predicting malignancy in patients with adrenal tumors using
18F-FDG-PET/CT SUVmax. J Surg Oncol. 122:1821–1826.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu B, Gao J, Cui L, Wang H, Guan Z, Yao S,
Shen Z and Tian J: Characterization of adrenal metastatic cancer
using FDG PET/CT. Neoplasma. 59:92–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Orzechowski S, Gnass M, Czyżewski D,
Wojtacha J, Sudoł B, Pankowski J, Zajęcki W, Ćmiel A, Zieliński M
and Szlubowski A: Ultrasound predictors of left adrenal metastasis
in patients with lung cancer: A comparison of computed tomography,
positron emission tomography-computed tomography, and endoscopic
ultrasound using ultrasound bronchoscope. Pol Arch Intern Med.
132:161272022.PubMed/NCBI
|
|
24
|
Noble WS: What is a support vector
machine? Nat Biotechnol. 24:1565–1567. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yin G, Song Y, Li X, Zhu L, Su Q, Dai D
and Xu W: Prediction of mediastinal lymph node metastasis based on
18F-FDG PET/CT imaging using support vector machine in
non-small cell lung cancer. Eur Radiol. 31:3983–3992. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang R, Zhu L, Cai Z, Jiang W, Li J, Yang
C, Yu C, Jiang B, Wang W, Xu W, et al: Potential feature
exploration and model development based on 18F-FDG PET/CT images
for differentiating benign and malignant lung lesions. Eur J
Radiol. 121:1087352019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nishino M, Jagannathan JP, Ramaiya NH and
Van den Abbeele AD: Revised RECIST guideline version 1.1: What
oncologists want to know and what radiologists need to know. AJR Am
J Roentgenol. 195:281–289. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang M, Su Q, Mouraux A and Iannetti GD:
Spatial patterns of brain activity preferentially reflecting
transient pain and stimulus intensity. Cereb Cortex. 29:2211–2227.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mendez AM, Petre EN, Ziv E, Ridouani F,
Solomon SB, Sotirchos V, Zhao K and Alexander ES: Safety and
efficacy of thermal ablation of adrenal metastases secondary to
lung cancer. Surg Oncol. 55:1021022024. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Andersen MB, Bodtger U, Andersen IR,
Thorup KS, Ganeshan B and Rasmussen F: Metastases or benign adrenal
lesions in patients with histopathological verification of lung
cancer: Can CT texture analysis distinguish? Eur J Radiol.
138:1096642021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Al Fares HK, Abdullaj S, Gokden N and
Menon LP: Incidental, solitary, and unilateral adrenal metastasis
as the initial manifestation of lung adenocarcinoma. Cureus.
14:e326282022.PubMed/NCBI
|
|
32
|
Hashimoto K, Nishimura S and Akagi M: Lung
adenocarcinoma presenting as a soft tissue metastasis to the
shoulder: A case report. Medicina (Kaunas). 57:1812021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lococo F, Patricelli G, Galeone C and
Rapicetta C: eComment. Surgery for isolated adrenal metastasis from
non-small-cell lung cancer: The role of preoperative PET/CT scan'.
Interact Cardiovasc Thorac Surg. 24:72017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Evans PD, Miller CM, Marin D, Stinnett SS,
Wong TZ, Paulson EK and Ho LM: FDG-PET/CT characterization of
adrenal nodules: Diagnostic accuracy and interreader agreement
using quantitative and qualitative methods. Acad Radiol.
20:923–929. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim BS, Lee JD and Kang WJ:
Differentiation of an adrenal mass in patients with non-small cell
lung cancer by means of a normal range of adrenal standardized
uptake values on FDG PET/CT. Ann Nucl Med. 29:276–283. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cho AR, Lim I, Na II, Choe du H, Park JY,
Kim BI, Cheon GJ, Choi CW and Lim SM: Evaluation of adrenal masses
in lung cancer patients using F-18 FDG PET/CT. Nucl Med Mol
Imaging. 45:52–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lu Y, Xie D, Huang W, Gong H and Yu J:
18F-FDG PET/CT in the evaluation of adrenal masses in lung cancer
patients. Neoplasma. 57:129–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Koopman D, van Dalen JA, Stigt JA, Slump
CH, Knollema S and Jager PL: Current generation time-of-flight
(18)F-FDG PET/CT provides higher SUVs for normal adrenal glands,
while maintaining an accurate characterization of benign and
malignant glands. Ann Nucl Med. 30:145–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Smith TA: Facilitative glucose transporter
expression in human cancer tissue. Br J Biomed Sci. 56:285–292.
1999.PubMed/NCBI
|
|
40
|
Zhang S, Li S, Pei Y, Huang M, Lu F, Zheng
Q, Li N and Yang Y: Impact of maximum standardized uptake value of
non-small cell lung cancer on detecting lymph node involvement in
potential stereotactic body radiotherapy candidates. J Thorac Dis.
9:1023–1031. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhu SH, Zhang Y, Yu YH, Fu Z, Kong L, Han
DL, Fu L, Yu JM and Li J: FDG PET-CT in non-small cell lung cancer:
Relationship between primary tumor FDG uptake and extensional or
metastatic potential. Asian Pac J Cancer Prev. 14:2925–2929. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sherlock M, Scarsbrook A, Abbas A, Fraser
S, Limumpornpetch P, Dineen R and Stewart PM: Adrenal
incidentaloma. Endocr Rev. 41:775–820. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen J, He Y, Zeng X, Zhu S and Li F:
Distinguishing between metastatic and benign adrenal masses in
patients with extra-adrenal malignancies. Front Endocrinol
(Lausanne). 13:9787302022. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ali MA, El-Abd E, Morsi M, El Safwany MM
and El-Sayed MZ: The effect of hepatic steatosis on 18F-FDG uptake
in PET-CT examinations of cancer Egyptian patients. Eur J Hybrid
Imaging. 7:192023. View Article : Google Scholar : PubMed/NCBI
|